My cancer journey taught me that nothing is certain; however, with support, humor and acceptance, we can weather the ups and ...

Prehabilitation and early screening, including BIS, can ease recovery, reduce side effects and help manage lymphedema after ...

Valarie Traynham sat down for an interview in CURE in which she discussed adjusting to life after cancer, detailing her ‘new normal.’ ...

New clinical trials are advancing in hard-to-treat cancers, offering targeted and less toxic options for patients with ...

A cancer thriver reflects on the emotional toll, survivorship, advocacy and support networks they wish they’d known at ...

It took years to understand why my mastectomy site looked different. Knowing I healed correctly for my procedure helped me ...

In a phase 2 study, 52% of patients treated with Bria-IMT plus a checkpoint inhibitor for metastatic breast cancer were alive at one year.

The FDA granted orphan drug designation to a CAR T-cell therapy for recurrent glioblastoma and high-grade astrocytomas.

I’ve survived rare blood cancer for 15 years, but the lasting side effects have taken a toll — even so, I still find purpose, ...

The FDA approved SIR-Spheres Y-90 resin microspheres for unresectable liver cancer, the only radioembolization approved in ...

Dr. Nicholas James discusses why it is important to identify which patients with high-risk prostate cancer will truly benefit ...

Mark Daniels, 83, says CAR T-cell therapy and strong support helped him overcome lymphoma twice and return to the ...